Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.

Journal of neurogenetics - 1 Jan 2000

Gascon Eduardo, Gao Fen-Biao

Abstract excerpt

Increasing evidence suggests that frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) share some clinical, pathological, and molecular features as part of a common neurodegenerative spectrum disorder. In recent years, enormous progress has been made in identifying both pathological proteins and genetic mutations associated with FTD-ALS. However, the molecular pathogenic mechanisms of disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to Amyotrophic Lateral Sclerosis Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Binding Proteins

Share to Frontotemporal Dementia

Share to MicroRNAs

Share to Mutation

Share to Neurogenetic and Muscular Disorders Research

Share to RNA Research and Splicing

Source

Open in PubMed Open full text

Identifiers

PMID: 24506814
DOI: 10.3109/01677063.2013.876021
PMCID: PMC4199862

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.PMID 24506814Read ↗

MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.Semantic proximity Read ↗

MicroRNAs in the pathogenesis of neurodegenerative disorders: Potential as therapeutic targetsSemantic proximity Read ↗

RNA Is a Double-Edged Sword in ALS PathogenesisSemantic proximity Read ↗

RNA Dysregulation in Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative DiseasesSemantic proximity Read ↗

Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patientsSemantic proximity Read ↗

MicroRNAs: newcomers into the ALS picture.Semantic proximity Read ↗

Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative DiseasesSemantic proximity Read ↗

Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.Semantic proximity Read ↗

MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapySemantic proximity Read ↗

MicroRNAs in Alzheimer’s DiseaseSemantic proximity Read ↗

An Overview of MicroRNAs as Biomarkers of ALSSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.